Retrospective analysis of sorafenib efficacy and safety in Chinese patients with high recurrence rate of post-hepatic carcinectomy

Background: There is no guideline recommendation for preventing hepatocellular carcinoma (HCC) recurrence after hepatic resection. Moreover, an unmet need exists on the effectiveness of sorafenib therapy in recurrent HCC. Purpose: We therefore assessed the efficacy and safety of sorafenib in Chinese...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Desheng, Jia, Weridong, Wang, Zhiming, Wen, Tianfu, Ding, Wei, Xia, Feng, Zhang, Ling, Wu, Feixiang, Peng, Tao, Liu, Bin, Zhou, Cuncai, Zheng, Qichang, Miao, Xiongying, Peng, Junping, Huang, Zhiyong, Dou, Kefeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643495/
https://www.ncbi.nlm.nih.gov/pubmed/31410023
http://dx.doi.org/10.2147/OTT.S168447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643495/
https://www.ncbi.nlm.nih.gov/pubmed/31410023
http://dx.doi.org/10.2147/OTT.S168447

Ejemplares similares